• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

家系中有非霍奇金淋巴瘤和浆细胞发育异常的家庭。

Families with non-Hodgkin lymphoma and plasma cell dyscrasias in their pedigrees.

作者信息

Wiernik Peter H, Dutcher Janice P

机构信息

Cancer Research Foundation of New York, Chappaqua, NY, USA.

出版信息

J Investig Med. 2024 Jan;72(1):26-31. doi: 10.1177/10815589231210516. Epub 2023 Nov 28.

DOI:10.1177/10815589231210516
PMID:37864488
Abstract

Although reports of familial clustering of hematologic malignancies have appeared for decades, the cause(s) of this uncommon occurrence is still not completely understood. Most modern investigations, however, support a genetic rather than an environmental exposure as a cause of this observation. Most pedigrees of families with familial hematologic malignancies demonstrate age of onset anticipation, with the disease diagnosed at an earlier age in successive generations. The cause of this phenomenon is clear in some familial neurologic disorders (trinucleotide repeat expansion) but not at all clear in familial hematologic malignancies. In preparation for molecular studies of familial clustering of hematologic malignancies, we have collected pedigrees on 738 families and have previously demonstrated anticipation in those with familial plasma cell myeloma, chronic lymphocytic leukemia, Hodgkin lymphoma or non-Hodgkin lymphoma (NHL). Here we present data on 36 families with both plasma cell myeloma and NHL in their pedigrees and demonstrate strong evidence for anticipation in these families. We encourage all health care personnel to ask patients multiple times about family medical history and carefully take note of family histories from individuals with uncommon illnesses and to refer families with clustering of such illnesses for further investigation.

摘要

尽管血液系统恶性肿瘤家族聚集性的报道已出现数十年,但这种不常见现象的原因仍未完全明了。然而,大多数现代研究支持遗传因素而非环境暴露是导致这一现象的原因。大多数患有家族性血液系统恶性肿瘤的家族谱系显示发病年龄提前,即后代被诊断出该病的年龄越来越早。这种现象在一些家族性神经系统疾病(三核苷酸重复序列扩增)中的原因很明确,但在家族性血液系统恶性肿瘤中则完全不清楚。为了准备对血液系统恶性肿瘤家族聚集性进行分子研究,我们收集了738个家族的谱系,并且之前已证明患有家族性浆细胞骨髓瘤、慢性淋巴细胞白血病、霍奇金淋巴瘤或非霍奇金淋巴瘤(NHL)的家族存在发病年龄提前现象。在此,我们展示了36个家族谱系中同时患有浆细胞骨髓瘤和NHL的家族的数据,并证明这些家族中存在发病年龄提前的有力证据。我们鼓励所有医护人员多次询问患者的家族病史,仔细记录患有罕见疾病个体的家族病史,并将此类疾病聚集的家族转介进行进一步调查。

相似文献

1
Families with non-Hodgkin lymphoma and plasma cell dyscrasias in their pedigrees.家系中有非霍奇金淋巴瘤和浆细胞发育异常的家庭。
J Investig Med. 2024 Jan;72(1):26-31. doi: 10.1177/10815589231210516. Epub 2023 Nov 28.
2
Families with both Hodgkin lymphoma and multiple myeloma in their pedigrees.家系中既有霍奇金淋巴瘤又有多发性骨髓瘤的家族。
Clin Adv Hematol Oncol. 2015 Apr;13(4):257-60.
3
Familial myeloma and monoclonal gammopathy: a report of eight African American families.家族性骨髓瘤和单克隆丙种球蛋白病:八个非裔美国家庭的报告。
Am J Hematol. 2009 Jan;84(1):34-8. doi: 10.1002/ajh.21325.
4
Family history of hematopoietic malignancy and risk of lymphoma.造血系统恶性肿瘤家族史与淋巴瘤风险
J Natl Cancer Inst. 2005 Oct 5;97(19):1466-74. doi: 10.1093/jnci/dji293.
5
Anticipation in families with Hodgkin's and non-Hodgkin's lymphoma in their pedigree.家族谱系中有霍奇金淋巴瘤和非霍奇金淋巴瘤的家庭中的遗传早现现象。
Leuk Lymphoma. 2006 Oct;47(10):2115-27. doi: 10.1080/10428190600724928.
6
Familial risk for non-Hodgkin lymphoma and other lymphoproliferative malignancies by histopathologic subtype: the Swedish Family-Cancer Database.基于组织病理学亚型的非霍奇金淋巴瘤及其他淋巴增殖性恶性肿瘤的家族风险:瑞典家族癌症数据库
Blood. 2005 Jul 15;106(2):668-72. doi: 10.1182/blood-2005-01-0140. Epub 2005 Apr 5.
7
Clustering of cancer among families of cases with Hodgkin Lymphoma (HL), Multiple Myeloma (MM), Non-Hodgkin's Lymphoma (NHL), Soft Tissue Sarcoma (STS) and control subjects.霍奇金淋巴瘤(HL)、多发性骨髓瘤(MM)、非霍奇金淋巴瘤(NHL)、软组织肉瘤(STS)病例家族以及对照人群中癌症的聚集情况。
BMC Cancer. 2009 Feb 27;9:70. doi: 10.1186/1471-2407-9-70.
8
Anticipation in familial plasma cell dyscrasias.
Br J Haematol. 1998 Dec;103(3):696-703. doi: 10.1046/j.1365-2141.1998.01061.x.
9
Familiality of benign and malignant paraproteinemias. A population-based cancer-registry study of multiple myeloma families.良性和恶性副蛋白血症的家族性。一项基于人群的骨髓瘤家族癌症登记研究。
Haematologica. 2005 Jan;90(1):66-71.
10
Age of onset evidence for anticipation in familial non-Hodgkin's lymphoma.家族性非霍奇金淋巴瘤中预期性发病年龄的证据。
Br J Haematol. 2000 Jan;108(1):72-9. doi: 10.1046/j.1365-2141.2000.01815.x.

引用本文的文献

1
Investigating additional malignancy rates and prognostic factors in multiple myeloma patients: a Surveillance, Epidemiology, and End Results (SEER) database retrospective cohort study.探究多发性骨髓瘤患者的额外恶性肿瘤发生率及预后因素:一项监测、流行病学与最终结果(SEER)数据库回顾性队列研究。
Transl Cancer Res. 2025 Apr 30;14(4):2192-2206. doi: 10.21037/tcr-24-1721. Epub 2025 Apr 14.